newsfilter
← Latest News
Business Wire·

AVROBIO Announces Leadership Transition

Current CFO Erik Ostrowski named interim CEO, replacing Founding President and CEO Geoff MacKay AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of